Immunofoco Presents Preclinical Data for IMV102, an In Vivo CAR-T Candidate, Demonstrating Durable Tumor Control at the AACR 2026

B SHANGHAI, April 20, 2026 /PRNewswire/ — Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at…
posteditor
posteditor
Articles: 16137

Other News